Cargando…

An Improved Synthesis of N-(4-[(18)F]Fluorobenzoyl)-Interleukin-2 for the Preclinical PET Imaging of Tumour-Infiltrating T-cells in CT26 and MC38 Colon Cancer Models

Positron emission tomography (PET) imaging of activated T-cells with N-(4-[(18)F]fluorobenzoyl)-interleukin-2 ([(18)F]FB-IL-2) may be a promising tool for patient management to aid in the assessment of clinical responses to immune therapeutics. Unfortunately, existing radiosynthetic methods are very...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khanapur, Shivashankar, Yong, Fui Fong, Hartimath, Siddesh V., Jiang, Lingfan, Ramasamy, Boominathan, Cheng, Peter, Narayanaswamy, Pradeep, Goggi, Julian L., Robins, Edward George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003786/ https://www.ncbi.nlm.nih.gov/pubmed/33808813 http://dx.doi.org/10.3390/molecules26061728

Ejemplares similares

Imaging Adipose Tissue Browning using Mitochondrial Complex-I Tracer [(18)F]BCPP-EF
por: Goggi, Julian L., et al.
Publicado: (2022)

Granzyme B PET Imaging in Response to In Situ Vaccine Therapy Combined with αPD1 in a Murine Colon Cancer Model
por: Hartimath, Siddesh V., et al.
Publicado: (2022)

Imaging Effector Memory T-Cells Predicts Response to PD1-Chemotherapy Combinations in Colon Cancer
por: Goggi, Julian L., et al.
Publicado: (2022)

Imaging Memory T-Cells Stratifies Response to Adjuvant Metformin Combined with αPD-1 Therapy
por: Goggi, Julian L., et al.
Publicado: (2022)

Dopamine transporter neuroimaging accurately assesses the maturation of dopamine neurons in a preclinical model of Parkinson’s disease
por: Goggi, Julian L., et al.
Publicado: (2020)

Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection
por: Chan, Yi-Hao, et al.
Publicado: (2020)

Granzyme B PET Imaging of Combined Chemotherapy and Immune Checkpoint Inhibitor Therapy in Colon Cancer
por: Goggi, Julian L, et al.
Publicado: (2021)

Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response
por: Goggi, Julian L., et al.
Publicado: (2022)

Imaging adipose tissue browning using the TSPO-18kDa tracer [(18)F]FEPPA
por: Hartimath, S.V., et al.
Publicado: (2019)

Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma
por: Goggi, Julian L., et al.
Publicado: (2021)

N′-(2-Fluorobenzoyl)benzohydrazide
por: Ejsmont, Krzysztof, et al.
Publicado: (2008)

Crystal structures of N-(3-fluorobenzoyl)benzenesulfonamide and N-(3-fluorobenzoyl)-4-methylbenzenesulfonamide
por: Suchetan, P. A., et al.
Publicado: (2016)

Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH)
por: Hartimath, S. V., et al.
Publicado: (2019)

N-(4-Fluorobenzoyl)-2-hydroxy-4-methylbenzohydrazide
por: Feng, Hai-Mei, et al.
Publicado: (2008)

1,1-Dibenzyl-3-(4-fluorobenzoyl)thiourea
por: Nasir, Mohd Faizal Md, et al.
Publicado: (2011)

3-[3-(2-Fluorobenzoyl)thioureido]propionic acid
por: Ngah, Nurziana, et al.
Publicado: (2014)

Development and preclinical evaluation of cixutumumab drug conjugates in a model of insulin growth factor receptor I (IGF-1R) positive cancer
por: Solomon, Viswas Raja, et al.
Publicado: (2020)

N-(4-Fluorobenzoyl)-N′,N′′-diisopropylphosphoric triamide
por: Pourayoubi, Mehrdad, et al.
Publicado: (2012)

(3,6-Dimethoxy-2-naphthyl)(4-fluorobenzoyl)methanone
por: Watanabe, Shoji, et al.
Publicado: (2010)

3-Fluoro-N-(3-fluorobenzoyl)-N-(2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2008)

2-Fluoro-N-(2-fluorobenzoyl)-N-(2-pyridyl)benzamide
por: Gallagher, John F., et al.
Publicado: (2009)

Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies
por: Shields, Nicholas J., et al.
Publicado: (2023)

Granzyme B PET Imaging of Immune Checkpoint Inhibitor Combinations in Colon Cancer Phenotypes
por: Goggi, J. L., et al.
Publicado: (2020)

1,8-Bis(4-fluorobenzoyl)naphthalen-2,7-diyl dimethanesulfonate
por: Hijikata, Daichi, et al.
Publicado: (2013)

Crystal structure of 1-(2-fluorobenzoyl)-2,7-dimethoxynaphthalene
por: Mohri, Saki, et al.
Publicado: (2014)

3-(4-Fluorobenzoyl)-4-(4-fluorophenyl)-4-hydroxy-2,6-diphenylcyclohexane-1,1-dicarbonitrile
por: Narayana, B., et al.
Publicado: (2014)

Imaging the Proangiogenic Effects of Cardiovascular Drugs in a Diabetic Model of Limb Ischemia
por: Goggi, J. L., et al.
Publicado: (2019)

N,N,N′,N′-Tetraethyl-N′′-(2-fluorobenzoyl)phosphoric triamide
por: Tarahhomi, Atekeh, et al.
Publicado: (2011)

(2,7-Dimethoxynaphthalene-1,8-diyl)bis(4-fluorobenzoyl)dimethanone
por: Watanabe, Shoji, et al.
Publicado: (2010)

Clinical-grade N-(4-[(18)F]fluorobenzoyl)-interleukin-2 for PET imaging of activated T-cells in humans
por: van der Veen, Elly L., et al.
Publicado: (2019)

Synthesis and Characterization in Rodent Brain of the Subtype-Selective NR2B NMDA Receptor Ligand [(11)C]Ro04-5595 as a Potential Radiotracer for Positron Emission Tomography
por: Jakobsson, Jimmy E., et al.
Publicado: (2019)

Decisions taken at the 38th meeting on 26 - 27 May 1998
por: Bradamante, Franco, et al.
Publicado: (1998)

Non-Invasive Multimodality Imaging Directly Shows TRPM4 Inhibition Ameliorates Stroke Reperfusion Injury
por: Chen, Bo, et al.
Publicado: (2018)

MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer
por: Huot, Joshua R., et al.
Publicado: (2021)

N,N′-Dicyclohexyl-N′′-(3-fluorobenzoyl)-N,N′-dimethylphosphoric triamide
por: Pourayoubi, Mehrdad, et al.
Publicado: (2011)

N-(3-Fluorobenzoyl)-N′,N′′-bis(4-methylphenyl)phosphoric triamide
por: Pourayoubi, Mehrdad, et al.
Publicado: (2011)

2-Chloro-N-[2-(2-fluorobenzoyl)-4-nitrophenyl]-N-methylacetamide
por: Siddaraju, B. P., et al.
Publicado: (2011)

2-(1H-Benzotriazol-1-yl)-1-(2-fluorobenzoyl)ethyl 4-methylbenzoate
por: Zeng, Wu-Lan, et al.
Publicado: (2009)

N-(2-Fluorobenzoyl)-N′,N′′-bis(4-methylphenyl)phosphoric triamide
por: Pourayoubi, Mehrdad, et al.
Publicado: (2011)

Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation
por: Di Gialleonardo, Valentina, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_atr6gubipfur5fal1mv3uthmce